The role of endoscopic ultrasound in the evaluation of rectal cancer

Ali A. Siddiqui, Yomi Fayiga, Sergio Huerta

Research output: Contribution to journalReview articlepeer-review

64 Scopus citations


Accurate staging of rectal cancer is essential for selecting patients who can undergo sphincter-preserving surgery. It may also identify patients who could benefit from neoadjuvant therapy. Clinical staging is usually accomplished using a combination of physical examination, CT scanning, MRI and endoscopic ultrasound (EUS). Transrectal EUS is increasingly being used for locoregional staging of rectal cancer. The accuracy of EUS for the T staging of rectal carcinoma ranges from 80-95% compared with CT (65-75%) and MR imaging (75-85%). In comparison to CT, EUS can potentially upstage patients, making them eligible for neoadjuvant treatment. The accuracy to determine metastatic nodal involvement by EUS is approximately 70-75% compared with CT (55-65%) and MR imaging (60-70%). EUS guided FNA may be beneficial in patients who appear to have early T stage disease and suspicious peri-iliac lymphadenopathy to exclude metastatic disease.

Original languageEnglish (US)
Article number36
JournalInternational Seminars in Surgical Oncology
StatePublished - Oct 18 2006

ASJC Scopus subject areas

  • Surgery
  • Oncology


Dive into the research topics of 'The role of endoscopic ultrasound in the evaluation of rectal cancer'. Together they form a unique fingerprint.

Cite this